aid: inventisbio accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/inventisbio.png name: InventisBio description: >- InventisBio Co., Ltd. (Shanghai Stock Exchange STAR Market: 688382) is a clinical-stage biopharmaceutical company headquartered in the Pudong New Area of Shanghai, China, with operations in New Jersey, United States. Built on independent R&D capabilities, InventisBio discovers and develops innovative small-molecule and targeted therapies for oncology, autoimmune, and metabolic diseases to address unmet medical needs. The company has advanced multiple drug candidates into clinical trials, including late-stage Phase III programs in non-small cell lung cancer and breast cancer, alongside earlier-stage assets targeting KRAS G12C, synthetic-lethal pathways, hyperuricemia/gout, and plaque psoriasis. It was added to the API Evangelist network as a portfolio company of Qiming Venture Partners. InventisBio is a research-driven pharmaceutical company and does not currently publish a public developer API, SDKs, or API documentation. url: https://raw.githubusercontent.com/api-evangelist/inventisbio/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - qiming x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Biotechnology - Pharmaceuticals - Oncology - Autoimmune Disease - Metabolic Disease - Clinical Trials - Drug Discovery - China apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/inventisbio-domain-security.yml - type: Website url: https://inventisbio.com - type: Blog name: News & Information url: https://www.inventisbio.com/en/news-information/ - type: Support name: Contact Us url: https://www.inventisbio.com/en/contact-us-2/ x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence